Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.
Disclosed holdings over time 53 weekly points
What the 3 currently disclosed positions would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.
How the line is built
Share counts are as last reported to the SEC and held constant; only prices move.
Insider activity Jul 10, 2024 – Jan 6, 2026
Nancy Lurker is recorded in filings to the U.S. SEC via EDGAR as officer and board member, and reported 19 transactions between Jul 10, 2024 and Jan 6, 2026. The buy and sell totals below count only codes P, S.
Why the other codes are excluded
Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.
Reported transactions
Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 25 most recent rows are grouped into 23 lines by date, company and transaction type — open a line to see every lot with its own source link.
How to read this list
Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.
The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.
-
Alkermes plc. ALKS F Shares withheld for taxesnot a buy/sell decision 1,475 shares $54.5K at $36.95 SEC filing ↗
-
Alkermes plc. ALKS M Option exercise or conversionnot a buy/sell decisionreported at zero 6,142 shares $0 at $0.00 SEC filing ↗
-
COLLEGIUM PHARMACEUTICAL, INC COLL A Grant or awardnot a buy/sell decisionreported at zero 8,741 shares $0 at $0.00 SEC filing ↗
-
Alkermes plc. ALKS F Shares withheld for taxesnot a buy/sell decision 901 shares $30.1K at $33.36 SEC filing ↗
-
Alkermes plc. ALKS M Option exercise or conversionnot a buy/sell decisionreported at zero 3,751 shares $0 at $0.00 SEC filing ↗
-
EyePoint, Inc. EYPT M Option exercise or conversionnot a buy/sell decisionreported at zero 75,133 shares $0 at $0.00 SEC filing ↗
-
EyePoint, Inc. EYPT M Option exercise or conversionnot a buy/sell decisionreported at zero 12,666 shares $0 at $0.00 SEC filing ↗
-
EyePoint Pharmaceuticals, Inc. EYPT M Option exercise or conversionnot a buy/sell decisionreported at zero 11,111 shares $0 at $0.00 SEC filing ↗
-
Alkermes plc. ALKS F Shares withheld for taxesnot a buy/sell decision 1,924 shares $58.9K at $30.61 SEC filing ↗
-
Alkermes plc. ALKS M Option exercise or conversionnot a buy/sell decisionreported at zero 8,013 shares $0 at $0.00 SEC filing ↗
-
COLLEGIUM PHARMACEUTICAL, INC COLL A Grant or awardnot a buy/sell decisionreported at zero 9,791 shares $0 at $0.00 SEC filing ↗
-
Alkermes plc. ALKS F Shares withheld for taxes × 2not a buy/sell decision 1,459 shares $39.4K
The 2 lots that make up this line, each with the source behind it. Shares Price Value Filing 558 $27.00 $15.1K SEC filing ↗ 901 $27.00 $24.3K SEC filing ↗ -
Alkermes plc. ALKS M Option exercise or conversion × 2not a buy/sell decisionreported at zero 6,075 shares $0
The 2 lots that make up this line, each with the source behind it. Shares Price Value Filing 3,752 $0.00reported at zero $0 SEC filing ↗ 2,323 $0.00reported at zero $0 SEC filing ↗ -
EyePoint Pharmaceuticals, Inc. EYPT M Option exercise or conversionnot a buy/sell decisionreported at zero 20,000 shares $0 at $0.00 SEC filing ↗
-
COLLEGIUM PHARMACEUTICAL, INC COLL A Grant or awardnot a buy/sell decisionreported at zero 12,726 shares $0 at $0.00 SEC filing ↗
-
EyePoint Pharmaceuticals, Inc. EYPT M Option exercise or conversionnot a buy/sell decisionreported at zero 75,134 shares $0 at $0.00 SEC filing ↗
-
EyePoint Pharmaceuticals, Inc. EYPT M Option exercise or conversionnot a buy/sell decisionreported at zero 12,667 shares $0 at $0.00 SEC filing ↗
-
EyePoint Pharmaceuticals, Inc. EYPT P Open-market purchase 3,173 shares $25.0K at $7.88 SEC filing ↗
-
EyePoint Pharmaceuticals, Inc. EYPT M Option exercise or conversionnot a buy/sell decisionreported at zero 11,111 shares $0 at $0.00 SEC filing ↗
Disclosed holdings
Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.
What is not counted here
Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.
| Issuer | Ticker | Security | Shares | Close | Value | Form | Reported | Filing |
|---|---|---|---|---|---|---|---|---|
| EyePoint, Inc. | EYPT | Common Stock | 421,235 | $4.58 | $1.9M | 4 | EDGAR ↗ | |
| COLLEGIUM PHARMACEUTICAL, INC | COLL | Common Stock | 22,517 | $23.53 | $529.8K | 4 | EDGAR ↗ | |
| Alkermes plc. | ALKS | Ordinary Shares | 10,705 | $46.10 | $493.5K | 4 | EDGAR ↗ |
Other insiders at the same companies
People who also file with the SEC at a company where Nancy Lurker reports shares.
Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.
-
Blair Curtis Jackson
COO · Alkermes plc.
- Brian P. McKeon CFO · Alkermes plc.
- Carlos V Paya Board Member · COLLEGIUM PHARMACEUTICAL, INC
- Cato T. Laurencin Board Member · Alkermes plc.
- Christian Todd Nichols SVP · Alkermes plc.
- Christopher I Wright Board Member · Alkermes plc.
- Colleen Tupper CFO · COLLEGIUM PHARMACEUTICAL, INC
-
Craig C Hopkinson
EVP · Alkermes plc.
- David Angelo Daglio Jr. Board Member · Alkermes plc.
- David Dieter General Counsel · COLLEGIUM PHARMACEUTICAL, INC
-
David Joseph Gaffin
General Counsel · Alkermes plc.
- Emily Peterson Alva Board Member · Alkermes plc.
Sources
The filings linked in the tables above are the sources for every figure on this page.
Think a number here is wrong? Open the linked filing and compare — how to report it.
Profile record last refreshed Sep 8, 2026.